BrainStorm Cell Therapeutics (BCLI) Fails to deliver data

Key failure to deliver metrics for BrainStorm Cell Therapeutics:

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: A$0 M
• Last year FTD volume: A$0 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BrainStorm Cell Therapeutics (BCLI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BrainStorm Cell Therapeutics (BCLI) - since 2014

BrainStorm Cell Therapeutics (BCLI) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	A$29.33 M	A$0.23 B	🇺🇸 USA
Cytokinetics CYTK	A$11.58 M	A$0.12 B	🇺🇸 USA
Seagen SGEN	N/A	A$7.95 M	🇺🇸 USA
Biogen BIIB	A$7.66 M	A$69.08 M	🇺🇸 USA
Agenus AGEN	N/A	A$4.54 M	🇺🇸 USA